Skip to content

"Fatty" signatures: How lipid patterns can be used as a diagnostic tool

Dortmund, 8th August 2024

When pathogens attack our brain or spine, they're on the scene right away: microglial cells are a type of immune cell found in the central nervous system. They can play a key role in the development of neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease or multiple sclerosis. Microglial cells are known for their ability to exhibit different phenotypes (observable characteristics) despite having an identical genetic blueprint. This heterogeneity at RNA and protein level has been known for a long time. But now researchers from the Justus Liebig University Giessen, Imperial College London and ISAS have been able to show for the first time that this heterogeneity also exists at lipid and, therefore, metabolic level for single cells. To do this, the scientists recorded the lipid signatures of single microglial cells: their unique, “fatty” signature. Until now it had only been possible to observe heterogeneity in cell cultures. The authors presented their research findings in the journal Analytical Chemistry.

Lipids are a molecular all-rounder: they form part of cell membranes, play an important role in a person's hormonal balance and provide cells with energy. Researchers describe the quantity, type and chemical structure of all the lipids in a particular area, such as a tissue or blood sample, using the lipid signature. They can use this unique signature to identify single cells and deduce how a particular cell metabolises the nutrients that are made available to it. So, the lipid signature helps to clarify which metabolic pathways may be affected by conditions such as Parkinson's disease, tumours or heart attacks. These diseases are highly heterogeneous, not all cells are affected equally and they have very different lipid signatures as a result.

Das Foto zeigt Jun.-Prof. Dr.-Ing. Sven Heiles und Doktorandin Chiahsin Chi am MALDI-Massenspektrometer.

The team around Professor Dr-Ing. Sven Heiles, head of the Lipidomics junior research group, combines complementary techniques such as imaging mass spectrometry (MALDI: matrix-assisted laser desorption/ionisation) and light or fluorescence microscopy for their analyses. The photo shows Heiles (left) and doctoral student Chiahsin Chi at the MALDI mass spectrometer.

© ISAS / Hannes Woidich

The researchers used atmospheric pressure matrix-assisted laser desorption/ionization mass spectrometry (AP MALDI-MSI, see infobox) to decipher the signature of the microglial cells. Firstly, the scientists used laser beams to break the samples down into their molecular components so they could determine their type and frequency. Then they transformed this information into an image by means of software, which they could then use to determine the lipid signature and spatial distribution.

Better lasers allow for a higher resolution

To be able to detect the lipid signature of the minuscule cells involved, the authors first had to improve the local resolution of the chemical analysis. They used a specially made ionisation source , adjusted the laser energy and optimised the distance between the MS inlet capillary and the laser focal point. One single microglial cell has a diameter of 45 µm. Thanks to these optimisations, the researchers were ultimately able to maintain the signal intensity and record more than 100 different species of lipid per pixel.

AP MALDI-MSI

Atmospheric pressure matrix-assisted laser desorption/ionization mass spectrometry is a mass spectrometry imaging procedure. AP MALDI-MSI is especially suitable for analysing small biomolecules such as metabolites and lipids. A sample, such as a microglial cell in the case of the specified publication is exposed to a laser beam. This causes a fraction of the ablated sample material to desorb and ionise. A mass spectrometer can be used to detect the escaping molecular ions. The masses of the molecular ions are determined during this process, like on a scale. The measurements are usually accurate enough that conclusions can be drawn about the elemental composition and, thus, the type of biomolecule. The laser irradiation of the sample is repeated in the lab point by point. The researchers then obtain specialised software distribution images of the individual molecular ions..

Tell-tale fats point to inflammation

The researchers studied microglial cells in order to test their method on single cells. The authors simulated a bacterial inflammation and compared untreated cells against those stimulated with lipopolysaccharides (LPS). LPS is a molecule that is present in bacterial membranes. Treating cells with LPS therefore suggests an infection to them. The cells react to the supposed bacterial attack with an immune response designed to fight off the fictitious attackers. During this process, however, single cells “wear out” and can no longer handle the energy that is generated. These subgroups of cells store this excess energy in the form of triglycerides in lipid droplets. Triglycerides are lipids used by an organism to store energy. They can be found in lipid droplets or fat tissue, for example. The scientists were able to use the AP MALDI-MSI method that has been developed to distinguish the still active cells from the population of “worn out” cells. This allowed the researchers to show the heterogeneity of single microglial cells within a cell population at lipid level for the first time.

Article Recommendation

Müller, M.A., Zweig, N., Spengler, B., Weinert, M., Heiles, S.

(2023) Lipid Signatures and Inter-Cellular Heterogeneity of Naive and Lipopolysaccharide-Stimulated Human Microglia-like Cells. Analytical Chemistry, 95, 11672 – 11679. https://doi.org/10.1021/acs.analchem.3c01533.

Optimised treatment plans: The lipid signature could help

The Lipidomics junior research group at ISAS is collaborating with scientists from University Hospital Essen who are conducting research into skin cancer. Together, they want to use the lipid signature to determine whether heterogeneous behaviour – in this case, the aggressiveness of melanoma cells – depends on the lipid metabolism. In the long term, the ISAS researchers want to shed more light on how different cell types interact in living organisms. In future, the lipid signature could help to detect diseases such as skin cancer in diagnostic tissue – and, together with partners from clinical practice, to optimise treatments.

(Luisa Becher)

Share

Further articles

8th November 2024

Using the Russian Doll Principle to Analyse Biological Structures

In the “AI-assisted imaging of large tissues” project, several ISAS research groups are working on combining various microscopic and mass spectrometric methods. Much like looking at a Russian doll, the team looks deeper into the biological structures of a sample with each step.

Flora Weber at the lightsheet fluorescence microscope.
31st October 2024

AI in Healthcare: Why Is it Better to Think Small Instead of Big?

Sustainability is an important topic when it comes to artificial intelligence in health research. A group of international researchers, including from ISAS, has been working on this topic and published a Perspective in Nature Machine Intelligence. In the interview, Prof Dr Yiyu Shi talks about the resource problem and possible solutions.

Portrait von Prof. Dr. Yiyu Shi.
25th October 2024

Valuable Connections: Dr Saskia Venne

Dr Saskia Venne completed her doctorate at ISAS from 2012 to 2016. Today she is a team leader at Boehringer Ingelheim Pharma. In this interview, she is the first to provides an insight into the valuable connections in- and outside the institute that current and former ISAS researchers will be reporting on in ISAS Kompakt over the coming weeks.

Dr. Saskia Venne.
21st October 2024

Between Progress and Footprint: Artificial Intelligence in Healthcare

The potential applications of artificial intelligence in healthcare are constantly increasing. However, with ever better and faster models, the question of sustainability is also coming to the fore. A group of international researchers, including Dr Jianxu Chen from ISAS's AMBIOM group, has been looking into the increased consumption of resources and possible solutions to the impending sustainability problem.

Dr. Jianxu Chen (links) und Prof. Dr. Yiyu Shi im Foyer des ISAS.
15th October 2024

Science Meets Art: Immersion in the Secret World of the Immune System

Diving into the smallest structures of the heart via microscope images? This was possible at the first Dortmund Science Night. "The secret world of the immune system", the immersive 3D experience by storyLab kiU at Fachhochschule Dortmund University of Applied Sciences and Arts and ISAS, gave visitors the chance to experience immune cells up close after a heart attack.

Das Foto zeigt (v.l.n.r.) Dr. Malte Roeßing, Dr. Ali Ata Tuz, Lara Janz, Flora Weber, Sara Regein und Cheyenne Peters vor dem Stand des ISAS bei der Science Night 2024.
20th September 2024

"Book a Scientist": Register Now for a Virtual Chat with Researchers

The format "Book a Scientist" offers those interested in science the opportunity to book individual appointments with researchers within the Leibniz Association. Among them are two ISAS researchers. Their topics are "overzealous" immune cells after a heart attack and animal experiments and their alternatives.

Book a Scientist.
10th September 2024

Fascinating Insights: Virtual World in the Classroom

What actually is reality? How do we perceive our environment? And how can augmented reality support researchers in their work? Along with class 3a of the Don Bosco elementary school in Bochum, two ISAS researchers explored these questions.

Marie steht im Klassenzimmer und trägt eine VR-Brille. In den Händen hält sie jeweils einen Controller.
29th August 2024

Protein interaction paralyses a young patient

Two mutations in the genetic material of a boy lead to the rare neuromuscular disease NEDHFBA. Investigations of the young patient's samples by researchers at Essen University Hospital and ISAS shed light on the previously unrecognized mechanisms behind the symptoms: Proteins influence the development of the rare disease.

Bild von Dr. Andreas Hentschel, Mitarbeiter in der Arbeitsgruppe Translationale Analytik.
16th August 2024

"We want to improve the fundamental understanding of disease models"

Why is it exciting to decode the lipid signature of individual cells? And which cell type is particularly suitable for allowing this process? Prof Dr Sven Heiles gives the answers in an interview.

Portrait von Jun.-Prof. Dr. Sven Heiles.